Acrivon Therapeutics Reports First Quarter 2024 Financial Results and Business Highlights WATERTOWN, Mass., May 14, 2024 (GLOBE NEWSWIRE) -- Acrivon Therapeutics, Inc. (“Acrivon” or “Acrivon Therapeutics”) (Nasdaq: ACRV), a clinical stage biopharmaceutical company developing precision oncology medicines that it matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proprietary proteomics-based patient responder identification platform, Acrivon Predictive Precision Proteomics (AP3), today reported financial results for the first quarter en...
BRT Apartments Corp. Files First Quarter 2024 Financial Statements GREAT NECK, N.Y., May 08, 2024 (GLOBE NEWSWIRE) -- BRT APARTMENTS CORP. (NYSE:BRT), a real estate investment trust that owns, operates, and, to a lesser extent, holds interests in joint ventures that own multi-family properties, announced that it has filed its quarterly report on Form 10-Q for the quarter ended March 31, 2024 with the Securities and Exchange Commission. The financial statements and can be accessed on the Company’s investor relations under the caption “Financials – Quarterly Results.” BRT is a real e...
America’s Car-Mart, Inc. to Announce the Fourth Quarter and Full Fiscal Year 2024 Results Conference Call Moved Earlier to 9am ET ROGERS, Ark. , May 08, 2024 (GLOBE NEWSWIRE) -- America’s Car-Mart, Inc. (NASDAQ: CRMT) today announced it will release fourth quarter and full fiscal year financial results on Tuesday, June 18, 2024, before the market opens and senior management will host a conference call at 9:00 a.m ET to discuss the results. Participants may access the conference call via webcast using this link: . To participate via telephone, please register in advance using this . Upo...
America’s Car-Mart, Inc. Schedules Release of Fourth Quarter Fiscal Year 2024 Results and Conference Call ROGERS, Ark., May 06, 2024 (GLOBE NEWSWIRE) -- America’s Car-Mart, Inc. (NASDAQ: CRMT) today announced it will release fiscal 2024 fourth quarter financial results on Tuesday, June 18, 2024, before the market opens, and senior management will host a conference call at 11:00 a.m. ET to discuss the results. Participants may access the conference call via webcast using this link: . To participate via telephone, please register in advance using this . Upon registration, all telephone par...
America’s Car-Mart to Acquire Texas Auto Center ROGERS, Ark., May 02, 2024 (GLOBE NEWSWIRE) -- America’s Car-Mart, Inc. (NASDAQ:CRMT), today announced that it has entered into a definitive agreement to purchase the dealership assets of Texas Auto Center (“TAC”). The transaction, which excludes legacy finance receivables, is expected to close in the first quarter of Car-Mart’s 2025 fiscal year, which begins May 1, 2024. Since founding Texas Auto Center in 1995, Bob and Erika Blankenship have grown their operation into an award-winning dealership group with locations in Austin and San ...
BRT Apartments Corp. Announces Filing Date for First Quarter 2024 Earnings Results GREAT NECK, N. Y., April 25, 2024 (GLOBE NEWSWIRE) -- BRT APARTMENTS CORP. (NYSE:BRT), a real estate investment trust that owns, operates, and, to a lesser extent, holds interests in joint ventures that own multi-family properties, today announced it intends to file its Form 10-Q for the quarter ended March 31, 2024 with the Securities and Exchange Commission on or about May 9, 2024. The Company does not intend to conduct an earnings call to discuss the results. BRT is a real estate investment trust that ...
Acrivon Therapeutics Reports Initial Positive Clinical Data for ACR-368 and Pipeline Program Progress Today at Corporate R&D Event • Initial ACR-368 Phase 2b clinical data in patients with ovarian or endometrial cancers (n=26; 10 OncoSignature-positive and 16 OncoSignature-negative) are being presented• A 50% confirmed overall response rate observed with ACR-368 in OncoSignature-positive gynecological (ovarian and endometrial) cancers• Initial clinical validation of AP3 patient selection platform, demonstrated ability to prospectively predict ACR-368 RECIST responders (p-value = 0.0038)•...
A director at BRT Apartments Corp bought 18,350 shares at 16.706USD and the significance rating of the trade was 53/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years c...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.